Manufacturers Life Insurance Company, The Rapt Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 25,325 shares of RAPT stock, worth $31,149. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,325

Previous 25,325 -0.0%

Holding current value

$31,149

Previous $77,000 35.06%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.89 - $9.38 $31,396 - $101,904	-10,864 Reduced 30.02%	25,325 $77,000
Q1 2024 May 14, 2024	SELL	$6.87 - $26.45 $55,647 - $214,245	-8,100 Reduced 18.29%	36,189 $324,000
Q4 2023 Feb 13, 2024	SELL	$11.28 - $25.46 $208,454 - $470,500	-18,480 Reduced 29.44%	44,289 $1.1 Million
Q3 2023 Nov 15, 2023	BUY	$16.34 - $24.66 $653 - $986	40 Added 0.06%	62,769 $1.04 Million
Q2 2023 Aug 11, 2023	BUY	$16.06 - $21.61 $22,773 - $30,642	1,418 Added 2.31%	62,729 $1.17 Million
Q4 2022 Aug 11, 2023	SELL	$16.28 - $24.6 $2,344 - $3,542	-144 Reduced 0.23%	61,311 $1.21 Million
Q4 2022 Feb 13, 2023	SELL	$16.28 - $24.6 $2,344 - $3,542	-144 Reduced 0.23%	61,311 $1.21 Million
Q3 2022 Aug 11, 2023	SELL	$17.96 - $30.46 $5,388 - $9,138	-300 Reduced 0.49%	61,455 $1.48 Million
Q3 2022 Nov 03, 2022	SELL	$17.96 - $30.46 $5,388 - $9,138	-300 Reduced 0.49%	61,455 $1.47 Million
Q2 2022 Aug 11, 2023	BUY	$10.26 - $23.59 $68,464 - $157,416	6,673 Added 12.11%	61,755 $1.13 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $23.59 $68,464 - $157,416	6,673 Added 12.11%	61,755 $1.13 Million
Q1 2022 Aug 11, 2023	SELL	$17.02 - $40.22 $106,017 - $250,530	-6,229 Reduced 10.16%	55,082 $1.21 Million
Q1 2022 May 20, 2022	BUY	$17.02 - $40.22 $745,663 - $1.76 Million	43,811 Added 388.71%	55,082 $1.2 Million
Q4 2021 Feb 16, 2022	BUY	$29.5 - $39.5 $2,360 - $3,160	80 Added 0.71%	11,271 $414,000
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $14,183 - $18,748	475 Added 4.43%	11,191 $347,000
Q2 2021 Aug 12, 2021	BUY	$17.99 - $40.02 $192,780 - $428,854	10,716 New	10,716 $341,000
Q4 2020 Feb 12, 2021	SELL	$15.89 - $40.87 $110,594 - $284,455	-6,960 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$21.6 - $37.5 $150,336 - $261,000	6,960 New	6,960 $224,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $36.5M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Rapt Therapeutics, Inc. Transaction History